Deep Oncology Expertise

Make Critical Oncology Decisions Confidently

Evolving and Unprecedented Challenges in Oncology

Oncology is perhaps the best example of innovation in the healthcare industry. This dynamic and increasingly segmented market is fiercely competitive, even in niche disease areas. The rapidly evolving oncology market has broad implications across a variety of stakeholders.

Additionally, we’re in the midst of a technological boom – there are more data being collected from diverse sources that have the potential to inform even greater innovation in R&D, how treatments are delivered, and the impact that they have on an individual’s cancer experience. To gain a competitive advance in the oncology market, you need a team of experts with diverse experiences who have worked from early-stage preclinical programs and even novel platforms, through clinical development strategy, to commercialization across all stakeholder groups including discovery, clinical development, marketing, medical affairs, market access, business development, and lifecycle management/brand excellence.

Lumanity provides you with broad and deep oncology experience-driven strategic guidance and insights to provide actionable decisions and solutions to de-risk and optimize development of therapies to improve the lives of patients who are impacted by cancer.

Oncology Experts With Unique Perspectives

We Can Help You

Understand the nature and complexity of your oncology challenges, from preclinical compounds to marketed products, taking into account the dynamic and evolving standard of care, the intensely competitive pipeline activity, the current and future unmet needs, and the benchmarks for regulatory and commercial uptake
Make informed choices with oncology strategy experts who have a track record of success in facilitating our clients’ value inflection for their programs and companies
Leverage deep oncology experience to provide insights that increase the POS, accelerate timelines, and maximize ROI
Pressure test and challenge assumptions at the right time with the right experts
Set the strategic direction, and provide guidance and support to ensure executional excellence

Our Oncology Work in Action

Pembrolizumab Receives NICE Approval for Five New Indications

Learn how Lumanity helped Pembrolizumab receive a full recommendation from NICE after a single appraisal committee meeting. Read now.

1 / 4

Precise Indication Development and Commercialization Strategy

Our SPARC (Strategic Pathway Research in Cancer) framework helped our client both to validate indications already being pursued and to recognize new, promising indications for their product, including novel combination regimens to explore. Discover how.

2 / 4

Supporting a Precommercial Biotech Developing a Novel IT-delivered Radiation-enhancing Therapy

We supported our client over many projects over a five-year period, guiding the evolution of their thinking across multiple types of projects. Learn how.

3 / 4

Supporting a Precommercial Platform Biotech Developing Cell Therapies

Learn how Lumanity helped its client gain a deeper, holistic understanding of their potential optimal clinical development and combination strategies. Read now.

4 / 4

Medical affairs consulting teammates conferring

30+ years of driving impact for our clients in the oncology space

Proven Experience in Delivering Oncology Excellence

At Lumanity, our oncology experts have working knowledge and in-depth experience and insight into the biology of cancer, clinical development strategy, and regulatory approval processes. We have a deep understanding of the lived experience of cancer patients and how new treatments may impact their journey.

Additionally, our Oncology Center of Excellence allows us to share best practices, drive innovation, and ensure we are providing our clients with multi-disciplinary, insight-driven guidance and support. We work with clients of all sizes, from emerging biotechs to large pharmaceutical companies, academic institutions, cooperative groups, and medical societies. We are proud members of the cancer community, actively involved across the patient advocacy community.

Our Perspectives in Oncology

View all perspectives